Clinical Characteristics of Patients Responding to Once-Daily Basal Insulin Therapy in Korean Subjects with Type 2 Diabetes

@inproceedings{Song2015ClinicalCO,
  title={Clinical Characteristics of Patients Responding to Once-Daily Basal Insulin Therapy in Korean Subjects with Type 2 Diabetes},
  author={Sun Ok Song and You-Cheol Hwang and K J Ahn and Bong Soo Cha and Young Duk Song and Dae Wook Lee and Byung Wan Lee},
  booktitle={Diabetes therapy : research, treatment and education of diabetes and related disorders},
  year={2015}
}
INTRODUCTION A1chieve® (ClinicalTrials.gov identifier NCT00869908) was a 24-week observational study evaluating certain insulin analogs and not insulin analogs in general in 66,726 people with type 2 diabetes (T2D) in routine clinical care in 28 non-Western countries. This study demonstrated that insulin analogs improved self-management and metabolic control in patients with T2D. We investigated the effectiveness and clinical characteristics of patients with T2D showing better response to basal… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS

Similar Papers

Loading similar papers…